|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 125.5 USD | +0.81% |
|
-3.05% | +15.15% |
| May. 31 | Gilead's Trodelvy fails bladder cancer trial, modestly extends lung cancer survival | RE |
| May. 31 | Sector Update: Health Care | MT |
Feb 5 (Reuters) - Merck on Monday said it has agreed to buy Elanco Animal Health's aqua business for $1.3 billion in cash. (Reporting by Bhanvi Satija in Bengaluru; Editing by Savio D'Souza)
Price
|
Change
|
5d. change
|
Capi.
| ||
|---|---|---|---|---|---|
| 125.5 USD | +0.81% | -3.05% | 318B | ||
| 17.68 USD | +0.45% | +5.30% | 8.74B | ||
| 1st Jan change | Capi. | |
|---|---|---|
| +15.15% | 318B | |
| +40.73% | 739B | |
| +32.83% | 598B | |
| -6.30% | 353B | |
| +4.05% | 285B | |
| +15.00% | 240B | |
| -5.52% | 206B | |
| +6.17% | 164B | |
| -0.45% | 162B | |
| -.--% | 122B |
MERCK & CO., INC. 
